Plethora confident of PE drug US approval and partner
This article was originally published in Scrip
Executive Summary
UK speciality pharma company Plethora Solutions has said it is confident its premature ejaculation drug, PSD502 (lidocaine/prilocaine), will be approved soon in the US.